Teva boots its R&D chief; Ironwood grows the C-suite and Intercept taps new EVP of research
→ In the first major C-suite overhaul under new CEO Kåre Schultz, troubled Teva is parting ways with R&D chief Michael Hayden …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
